| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 10/15/2008 | EP1272515B1 Immunoregulator |
| 10/15/2008 | EP1242456B1 Scfv antibodies against disease associated molecules |
| 10/15/2008 | EP1233980B1 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 10/15/2008 | EP1200116B1 USE OF FVIIa OR A TISSUE FACTOR AGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS |
| 10/15/2008 | EP1045906B1 Apo-2 ligand |
| 10/15/2008 | EP1019057B1 A method of preventing or treating estrogen-dependent diseases and disorders |
| 10/15/2008 | EP0915708B1 Immunogenic composition comprising tumor associated antigen and human cytokine |
| 10/15/2008 | CN101287831A T-cell receptor and nucleic acid encoding the receptor |
| 10/15/2008 | CN101287764A Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38 |
| 10/15/2008 | CN101287753A Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 10/15/2008 | CN101287737A Pentacyclic kinase inhibitors |
| 10/15/2008 | CN101287734A 2-氨基-7,8-二氢-6H-吡啶并[4,3-d]嘧啶-5-酮 2-amino-7,8-dihydro--6H- pyrido [4,3-d] pyrimidin-5-one |
| 10/15/2008 | CN101287733A Novel isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein Hsp90 activities |
| 10/15/2008 | CN101287725A DNA-PK inhibitors |
| 10/15/2008 | CN101287724A Solid salt forms of a pyrrole substituted 2-indolinone |
| 10/15/2008 | CN101287712A Heterocyclic compounds |
| 10/15/2008 | CN101287492A Anti-glypican-3 antibody |
| 10/15/2008 | CN101287481A A pharmaceutical composition useful for the treatment of hepatocellular carcinoma |
| 10/15/2008 | CN101287476A Scavenger of harmful active oxygen and/or free radical in living body |
| 10/15/2008 | CN101287475A Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment |
| 10/15/2008 | CN101287474A Therapeutic protocols using hyaluronan |
| 10/15/2008 | CN101287469A Regimen of administration for 5-(2-chlorophenyl)-1 ,2-dihydro-7-fluoro-8-methoxy-3-methyl-pyrazolo [3, 4.-b] [1, 4] benzodiazepine |
| 10/15/2008 | CN101287463A New pharmaceutical compositions comprising 4-(4-(3-(4-chloro-3-trifluoromethyl-phenyl)-ureido)-3-fluoro-phenoxy)-pyridine-2-carboxylic acid for the treatment of hyper-proliferative disorders |
| 10/15/2008 | CN101287454A Iontophoresis preparation for treatment of breast cancer and/or mastitis |
| 10/15/2008 | CN101287452A Solid pharmaceutical compositions comprising 1-(4-chloroanilino)-4-(4-pyridylmethyl) phthalazine and a ph modifier |
| 10/15/2008 | CN101284873A Compositions and methods for the therapy and diagnosis of lung cancer |
| 10/15/2008 | CN101284861A Triterpenoid saponin compounds, preparation method and use |
| 10/15/2008 | CN101284860A Antineoplastic pharmaceutical compositions, preparation method and applications thereof |
| 10/15/2008 | CN101284859A Panaxadiol saponin microbial conversion hydrolysate and method for preparing same |
| 10/15/2008 | CN101284853A Carbohydrate derivates, transient metal complex compounds, method for preparing same and use on treating cancer |
| 10/15/2008 | CN101284835A Dimeric sesquiterpene lactone compounds, preparation method and applications thereof |
| 10/15/2008 | CN101284834A Bi-inulicin 1, preparation method and applications thereof |
| 10/15/2008 | CN101284833A Bi-inulicin 4, preparation method and applications thereof |
| 10/15/2008 | CN101284827A Antineoplastic compounds containing triazole ring naphthoyl imines and method for preparing same |
| 10/15/2008 | CN101284820A Amino peptidase inhibiting substance and synthetic method |
| 10/15/2008 | CN101284792A Bisbenzylisoquinoline compounds, preparation method and applications |
| 10/15/2008 | CN101284133A Drug carried target cationic polymer for injections and modified by integrin ligand |
| 10/15/2008 | CN101284127A Injection for curing angiomatous |
| 10/15/2008 | CN101284120A Process for preparing Pingxiao preparation |
| 10/15/2008 | CN101284118A Qiankun Yilidan pellet |
| 10/15/2008 | CN101284116A Chinese medicine capsules for curing digestive system tumor |
| 10/15/2008 | CN101284107A Medicine for curing cancers and preparation method thereof |
| 10/15/2008 | CN101284095A Anti-cancer Chinese medicine |
| 10/15/2008 | CN101284056A Drug for curing rectal cancer |
| 10/15/2008 | CN101284052A Chinese medicinal materials compound prescription for treating the tumor |
| 10/15/2008 | CN101284032A Delicate fragrance vine formulations and preparation method thereof |
| 10/15/2008 | CN101284018A Medicine for treating mammary cancer |
| 10/15/2008 | CN101284008A IL-4R antagonist and microorganism for generating the IL-4R antagonist |
| 10/15/2008 | CN101284007A Pharmaceutical use of aryl group substituted pyridone derivates |
| 10/15/2008 | CN101284005A Application of indirubin for preparing medicine for preventing blood vessel from regenerating |
| 10/15/2008 | CN101284004A Application of two bi-sesquiterpenes compound for preparing antineoplastic and antiinflammatory medicine |
| 10/15/2008 | CN101283998A Application of bromine phenolic compound in preparing the medicine for curing the malignancy |
| 10/15/2008 | CN101283995A Different pharmaceutical uses alpha2delta ligands |
| 10/15/2008 | CN101283983A Stable camptothecine liposome composition |
| 10/15/2008 | CN101283978A Anticancer sustained-release gel injection containing platinum compound |
| 10/15/2008 | CN101283977A Sustained-release gel injection loaded with platinum compound and alkyl agent |
| 10/15/2008 | CN101283976A Anticancer sustained-release gel injection containing taxone medicine |
| 10/15/2008 | CN101283975A Anticancer sustained-release gel injection containing neonatal blood vessel inhibitor |
| 10/15/2008 | CN101283974A Anticancer sustained-release gel injection and preparation method thereof |
| 10/15/2008 | CN101283822A Functionality beverage containing burdock and preparation method thereof |
| 10/15/2008 | CN101283715A Health-care beverage health preservation tea |
| 10/15/2008 | CN100425700C scFvC6.5-sTrail fusion gene and protein, and its preparation |
| 10/15/2008 | CN100425699C scFvC6.5-TNF-alpha fusion gene and protein, and its preparation |
| 10/15/2008 | CN100425697C Nucleotid sequence of human interleukin 21 and method and application of producing matured human interleukin 21 |
| 10/15/2008 | CN100425695C Novel human Rab GTP enzyme, its coding sequence and application |
| 10/15/2008 | CN100425621C Steroid imidazole salt compound and its preparing process |
| 10/15/2008 | CN100425608C Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic |
| 10/15/2008 | CN100425600C Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as CDC25 phosphatase inhibitors |
| 10/15/2008 | CN100425592C Indole derivatives |
| 10/15/2008 | CN100425290C CCA gene vaccine, and its establishing method and use for preparing vaccine for preventing and treating tumour |
| 10/15/2008 | CN100425289C Inclusion complex of taxol with 2-hydroxypropyl-beta-cyclodextrin |
| 10/15/2008 | CN100425287C Tumor vaccines |
| 10/15/2008 | CN100425284C Methods for glucagon suppression |
| 10/15/2008 | CN100425252C Medicine for treating leukopenia |
| 10/15/2008 | CN100425247C Refining ganoderam lucidum spore oil and method for preparing same |
| 10/15/2008 | CN100425244C Aluminium sulfate for injection and aluminium sulfate injection for treating bladder tumor |
| 10/15/2008 | CN100425240C Use of the quinazoline derivative ZD6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeabi |
| 10/14/2008 | US7435832 Preparing an anhydrous crystal of a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide by reacting the acid and amine in a solvent and crystallizing under various process conditions |
| 10/14/2008 | US7435820 Substituted tetrahydro-1H-pyrazolo [3,4-c]pyridines compositions comprising them, and use |
| 10/14/2008 | US7435806 Detection of preferential transcription factor; obtain library, screen with probe, detect hybridization, recover clone, monitor transcriptional activity of protein codes in cloned nucleotide sequences |
| 10/14/2008 | US7435797 Anti-HER2 antibody variants |
| 10/14/2008 | US7435754 Laulimalide microtubule stabilizing agents |
| 10/14/2008 | US7435750 Method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 10/14/2008 | US7435745 Methods and compositions for inhibition of angiogenesis |
| 10/14/2008 | US7435743 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one |
| 10/14/2008 | US7435739 Antiproliferative agents; skin, prostate glands, kidneys, central nervous system |
| 10/14/2008 | US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder |
| 10/14/2008 | US7435729 using estrogen antagonist ; anticancer agents |
| 10/14/2008 | US7435726 Thalidomide and a topoisomerase inhibitor anticancer drug such as irinotecan; reduces toxicity related side effects of anticancer drug |
| 10/14/2008 | US7435595 Using prokaryotic histone protein as tool in transfer of heterologus nucleotide sequences into cells; improving exogenous gene expression |
| 10/14/2008 | US7435585 Auto-stimulating cells and methods for making and using the same |
| 10/14/2008 | US7435554 Immunoglobulin specific to lung cancer cell surface protein for use as tool in detection and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics; antitumor agents |
| 10/14/2008 | US7435415 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 10/14/2008 | CA2387727C Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them |
| 10/14/2008 | CA2379995C 11.beta.-aryl-17,17-spirothiolane-substituted steroids |
| 10/14/2008 | CA2338801C Tin polyoxaalkanecarboxylates and compositions containing them |
| 10/14/2008 | CA2279279C Lipid complexes and liposomes of highly insoluble platinum complexes |
| 10/14/2008 | CA2275351C Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them |
| 10/14/2008 | CA2255865C Synthesis of soluble beta-sheet forming peptides |
| 10/14/2008 | CA2171625C Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents |